Skip to main content
Ming Y. Lim
( out of 63 reviews )

Ming Y. Lim, MBBCh, MS

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Dr. Ming Y. Lim is an Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting people with congenital bleeding disorders, specifically persons with hemophilia with inhibitors and pregnant women with bleeding disorders.

Dr. Lim is the Medical Director for the Utah Center for Bleeding & Clotting Disorders at University of Utah Health. Nationally, she serves as the Chair of the American Board of Internal Medicine (ABIM) Hematology Longitudinal Knowledge Assessment Approval Committee and as the Education Officer for the Hemostasis and Thrombosis Research Society (HTRS). She also serves on the National Bleeding Disorders Foundation (NBDF) Medical and Scientific Advisory Council (MASAC) and on the National Comprehensive Cancer Network (NCCN) Cancer-Associated Venous Thromboembolic Disease Panel.

Board Certification

American Board of Internal Medicine (Internal Medicine)
National Certification Board for Anticoagulation Providers
Educational Commission for Foreign Medical Graduates
American Board of Internal Medicine (Sub: Hematology)

Patient Rating

4.9 /5
( out of 63 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

SUGAR HOUSE HEALTH CENTER

Was very carrying and kind. Answered all my questions and help me understand my health and I know I am in good hands.

SUGAR HOUSE HEALTH CENTER

Dr Lim is an excellent physician. she is caring and professional. she always addresses my concerns.

SUGAR HOUSE HEALTH CENTER

During my visit, I really appreciate how Dr Ming and her colleague (Dr Gretchen) attended to my health concern with their best knowledge and expertise to rule out underlying issue that may be causing my anemia.

SUGAR HOUSE HEALTH CENTER

She explained about why I was there and to take care of my next step

SUGAR HOUSE HEALTH CENTER

She is very nice and concerned about your health ,God bless her

SUGAR HOUSE HEALTH CENTER

Dr. Lim is amazing!

SUGAR HOUSE HEALTH CENTER

I trust Dr. Lim By far, she has been the most honest and thoughtful, upfront specialist I see. She is a God send.

SUGAR HOUSE HEALTH CENTER

Dr Lim is very easy to speak your concerns . She throughly makes you feel better

SUGAR HOUSE HEALTH CENTER

I love Dr Lim. She is so wonderful to work with, I am so glad that I found her. She answers my questions and takes her time with me. Thank you UHealth for having Dr Lim.

Dr. Ming Y. Lim is an Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting people with congenital bleeding disorders, specifically persons with hemophilia with inhibitors and pregnant women with bleeding disorders.

Dr. Lim is the Medical Director for the Utah Center for Bleeding & Clotting Disorders at University of Utah Health. Nationally, she serves as the Chair of the American Board of Internal Medicine (ABIM) Hematology Longitudinal Knowledge Assessment Approval Committee and as the Education Officer for the Hemostasis and Thrombosis Research Society (HTRS). She also serves on the National Bleeding Disorders Foundation (NBDF) Medical and Scientific Advisory Council (MASAC) and on the National Comprehensive Cancer Network (NCCN) Cancer-Associated Venous Thromboembolic Disease Panel.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Academic Divisions Hematology & Hematologic Malignancies
Board Certification
American Board of Internal Medicine (Internal Medicine)
National Certification Board for Anticoagulation Providers
Educational Commission for Foreign Medical Graduates
American Board of Internal Medicine (Sub: Hematology)

Education history

Graduate Training Medical Sciences - Magdalene College, University of Cambridge M.A.
Professional Medical Clinical Medicine - Cambridge University School of Clinical Medicine MB BChir
Diploma Palliative Medicine - Cardiff University School of Medicine Diploma
Residency Internal Medicine - Mayo School of Graduate Medical Education Resident
Fellowship Hematology/Oncology - University of North Carolina at Chapel Hill School of Medicine Fellow
Graduate Training Clinical Research - Medical University of South Carolina M.S.

Selected Publications

Journal Article

  1. Young A, Lim MY, Sanders J, Branch DW, Simonsen S (2023). Pregnancy and Childbirth in Women with Bleeding Disorders: A Retrospective Cohort Study. Haemophilia, 29(1), 240-247.
  2. Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz T (2022). Weight-Based Compared with Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstetrics and gynecology, 140(4), 575-583.
  3. Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA, United States Thrombotic Microangiopathies Consortiu (2022). Race, Rituximab, and Relapse in TTP. Blood, 140(12), 1335-1344.
  4. Cogan JC, McFarland MM, May JE, Lim M (2023). Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review. Research and practice in thrombosis and haemostasis, 7(7), 102219.
  5. Ragni MV, Callis J, Daoud N, Hu B, Manuel M, Santos J, Schwartz J, Friedman KD, Kouides P, Kuriakose P, Leavitt AD, Lim MY, Machin N, Recht M, Chrisentery-Singleton (2024). Observational cohort study of long-term outcomes of liver transplantation in haemophilia. Haemophilia, 30(1), 87-97.
  6. Wheeler AP, Lim MY, Huguelet PS, Jaffray J, Staber JM, Funkhouser K, Carpenter SL, Weyand A (2023). Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers. American journal of hematology, 98(12), E399-E402.
  7. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim M (2024). A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood advances, 8(3), 620-623.
  8. Lim MY, Rodgers GM, Branch DW, Simonsen S (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477.
  9. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Kreuziger LB, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim M (2024). A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis, 8(3), 102388.
  10. Lim MY, Abou-Ismail M (2024). Double-heterozygous FVL/PTGM: double the trouble. Blood, 143(23), 2347-2349.
  11. Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker (2024). Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(7), 483-506.
  12. Moshirfar M, Reynolds JC, Moin KA, Lim MY, Stoakes IM, Hoopes P (2024). Perioperative Recommendations for Corneal Refractive Surgery Patients With Inherited Bleeding Disorders. Cornea, 43(12), 1599-1607.
  13. Montgomery HD, Agarwal AM, Lim M (2022). A case of azathioprine-induced aplastic anemia. International journal of laboratory hematology, 44(6), 1015-1016.
  14. Simpson SJ, Lim MY, George TI, Rets (2022). 36-year-old male with X-linked congenital sideroblastic anemia presenting as chronic microcytic anemia with iron overload. International journal of laboratory hematology, 44(1), 69-71.
  15. Lim MY, Sivaloganathan V, Rodgers GM, Simonsen S (2025). Development and validation of an algorithm to better identify pregnant women with inherited bleeding disorders within electronic health records. Thrombosis research, 246, 109253.
  16. Fatola A, Evans MD, Brown J, Davis E, Johnson A, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Eubanks S, Akwaa F, Clover T, Kreuziger LB, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Lim MY, Kocher NK, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Mazepa M, Chaturvedi (2025). Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era. Blood advances, 9(2), 417-424.
  17. Parks AL, Jenkins SL, Vazquez SR, Swenson E, Lim MY, Moser KA, Witt D (2025). The clot cases conference: a proposed model to enhance multidisciplinary thrombosis care. Journal of thrombosis and thrombolysis, 59(1), 161-166.
  18. Lim MY, Funkhouser KB, Anguiano KC, Johnsen JM, Horowitz GS, Chupka J, Chitlur (2025). Mild Matters: A Survey of US Haematologists on the Diagnosis and Management of Individuals With Mild Haemophilia. Haemophilia,
  19. Lim MY, Anguiano KC, Carpenter SL, Funkhouser K (2025). Building access to care for Women and Girls(+) with Bleeding Disorders: the WGBD Clinic of Excellence Model. Research and practice in thrombosis and haemostasis, 9(7), 103203.
  20. Lim MY, Cogan JC, Cromwell C, Gaddh M, Gangaraju R, Morton C, Peseski A, Singh R, Tatake I, Youkhana K, Kreuziger L (2025). Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions. Thrombosis research, 255, 109493.
  21. Lim MY, Lee K, Johnsen JM, Key N (2025). F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A. Haemophilia, 31(6), 1217-1225.
  22. Lluís N, Kunzler F, Tsamalaidze L, Asbun D, Manresa-Rocamora A, Blasco-Peris C, Alseidi A, Chan C, Teh C, Conrad C, Ferrone C, Telem D, Targarona E, Vega EA, Reitano E, Romano F, Dudina G, Al-Samkari H, Khatkov I, Freed JA, Conlon K, Feldman LS, Cappellini MD, Barabanshikova MV, Giménez M, Nakamura M, Lim MY, Hilal MA, Dimachk M, Alexakis N, De'Angelis N, Bouvy ND, Marco P, Llamas P, Gangaraju R, Mehta RP, Sánchez-Cabús S, Ross SB, Perretta S, Taner T, Shen YM, Demetrashvili Z, Lluís F, Nagalla S, Asbun H (2025). Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines. International journal of surgery (London, England),
  23. Bruno AM, Job KM, Rower JE, Allshouse AA, Zinkhan EK, Lim MY, Shakib JH, Federspiel JJ, Watt KM, Metz TD, Branch D (2025). Prophylactic-Dose Rivaroxaban Transfer Into Human Milk. Obstetrics and gynecology,
  24. Tatake IJ, Singh R, Cromwell C, Bakow B, Cogan J, Gaddh M, Gangaraju R, Lim MY, Morton CT, Peseski AM, Rosovsky RP, Youkhana K, Kreuziger L (2025). Qualitative comparison of perioperative anticoagulation management guidelines across US institutions. Thrombosis research, 257, 109569.
  25. Batsuli G, Lewandowska MD, Lim MY, Tickle K, Baldwin MK, Bender R, Davila J, Hayes B, Jacobson-Kelly A, Kouides P, Lambert MP, Nataraj S, Sholzberg M, Sinha R, Al-Samkari H, Dunn A (2026). National Bleeding Disorder Foundation Clinical Practice Recommendations for Laboratory Screening of Iron Deficiency With and Without Anemia in the Inherited Bleeding Disorders Population. Haemophilia,
  26. Lim MY, Christensen GB, Rodgers GM, Simonsen S (2026). Pregnancy outcomes in women with Von Willebrand disease: a statewide cohort study. Research and practice in thrombosis and haemostasis, 10(2), 103383.
  27. Fedewa SA, Buckner TW, Cafuir L, Sidonio RF, Lim M, Kempton C (2026). Approaches to Identify People With Haemophilia With Medicare Claims Data. Haemophilia, 32(2), 410-417.
  28. Godby RC, Cogan J, Cuker A, Garcia D, Lim MY, Masias C, May JE, Morton CT, Schaefer JK, Shah S, Zumberg MS, Marshall A (2026). Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth. Blood advances, 10(6), 2038-2046.

Review

  1. Lim MY, Abou-Ismail MY, Branch D (2023). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstetrics and gynecology, 141(1), 85-108.
  2. Elshoury A, Schaefer JK, Lim MY, Skalla DP, Streiff M (2022). Update on Guidelines for the Prevention of Cancer-Associated Thrombosis. Journal of the National Comprehensive Cancer Network, 1-8.
  3. Baljevic M, Sborov DW, Lim MY, Hillengass J, Martin T, Castillo JJ, Streiff MB, Kumar SK, Callander N (2022). Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma. Journal of the National Comprehensive Cancer Network, 20(1), 91-95.
  4. Thomas VM, Abou-Ismail MY, Lim M (2022). Off-label Use of Emicizumab in Persons with Acquired Haemophilia A and von Willebrand Disease: A Scoping Review of the Literature. Haemophilia, 28(1), 4-17.
  5. Lim M (2021). How Do We Optimally Utilize Factor Concentrates in Persons with Hemophilia?. Hematology. American Society of Hematology. Education Program, 2021(1), 206-214.
  6. Branch DW, Lim M (2024). How I Diagnose And Treat Antiphospholipid Syndrome In Pregnancy. Blood, 143(9), 757-768.
  7. La Mura V, Colombo M, Foster GR, Angeli P, Miesbach W, Klamroth R, Pierce GF, O'Mahony B, Lim MY, Hernandez-Gea V, Makris M, Peyvandi (2024). The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia. Journal of thrombosis and haemostasis, 22(12), 3629-3639.
  8. Cogan JC, Burnett AE, Power-Hays A, Barnes GD, Lim M (2025). Identifying and addressing underuse in hematologic care through systems-based hematology. Research and practice in thrombosis and haemostasis, 9(4), 102881.
  9. Lewandowska M, Lim M (2025). The aging hemophilia patient. Hematology. American Society of Hematology. Education Program, 2025(1), 674-681.

Case Report

  1. Gleichgerrcht E, Lim MY, Turan T (2017). Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. The neurologist, 22(6), 241-244.